Establishing effectiveness for drugs intended to treat male hypogonadotropic hypogonadism attributed to nonstructural disorders
Guidance for industry
United States. Department of Health and Human Services, issuing body. United States. Food and Drug Administration, issuing body. Center for Drug Evaluation and Research (U.S.), issuing body.
Silver Spring, MD : Center for Drug Evaluation and Research, May 2018
Clinical Trials as Topic -- standards
Drug Evaluation -- standards
Hypogonadism -- drug therapy
United States. Department of Health and Human Services.
United States. Food and Drug Administration.
The National Library of Medicine believes this item to be in the public domain.
1 online resource (1 PDF file (4 pages)).
NLM Unique ID:
See catalog record
Metadata (Dublin Core)